Delivery Order SPE2DB20D1110-SPE2DB23FK44Q
Award Date 9/26/23
Potential Completion Date 9/27/23
Potential Value $6.8K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $28,577.16 delivery order contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of January 31, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order issued by the Defense Logistics Agency (DLA) for the pharmaceutical product XIFAXAN 550 MG TABLET 60S. The $20,358.39 firm fixed-price contract has a completion date of March 13, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,082.84 firm fixed-price delivery order is for the supply of XIFAXAN 550 mg tablets, a specialty pharmaceutical product. The contract has a completion date of February 10, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., the parent company. Cencora, Inc. holds a significant $999,999,999.00...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $8,572.70 and is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The ultimate completion date is April 24, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $15,735.93 delivery order is for the supply of XIFAXAN 550 mg tablets, a specialty medication, to support military and government healthcare programs. The contract has a completion date of September 8, 2022 and is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order valued at $6,879.15 for the supply of the pharmaceutical product XIFAXAN 550 MG TABLET 60S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through June 26, 2023. The contract is a Firm Fixed Price arrangement and was not designated as a set-aside. Amerisourcebergen is a major pharmaceutical distributor that holds several...
- This federal contract award, valued at $1,316.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a performance period ending on March 11, 2024. This is a firm-fixed-price delivery order contract, and there is no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $12,978.74, is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $12,978.74 and an ultimate completion date of November 20, 2023. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,656.73 Firm Fixed Price Delivery Order contract is for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of May 1, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen....
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distribution company, for the delivery of XIFAXAN 550 MG TABLET 60S. The contract, valued at $12,119.86, is a firm fixed-price delivery order with a completion date of May 19, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...